Skip to content

A Journey through Academia, Big Pharma and Biotech: Building Breakthrough Medicines with Dr. Briggs Morrison

August 4, 2026 · 27 min

Show notes

In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Briggs Morrison, CEO of Crossbow Therapeutics and former Chief Medical Officer and Head of Global Medicines Development at AstraZeneca. Briggs shares lessons from a career spanning academia, Big Pharma, and biotech entrepreneurship—including leadership roles at Merck, Pfizer, AstraZeneca, Syndax Pharmaceuticals, and now Crossbow. The conversation explores how small biotech companies drive innovation, why constraints can improve execution, and how leaders build teams capable of navigating scientific, clinical, and financial uncertainty. Briggs also discusses Crossbow's recent $77 million Series B financing, the promise of TCR mimetic antibody therapies, and the realities of raising capital in today's biotech environment. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen. Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Gianna Palmer and our production assistant is Joia Putnoi.

All episodes of Clinical Trialblazers

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.